Creative Medical Technology Holdings, Inc. Prepaid Expense and Other Assets, Current
Creative Medical Technology Holdings, Inc. (CELZ) had Prepaid Expense and Other Assets, Current of $70.46 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-07
- 2026-06-30: Prepaid Expense and Other Assets, Current $70.46K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $105.03K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $138.80K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $35.04K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $70.46K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $105.03K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $138.80K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $35.04K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $87.59K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $140.15K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $192.71K 10-K · filed 2026-03-20 |
| 2024-09-30 | $67.61K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $129.09K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $190.56K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $277.25K 10-K · filed 2025-03-14 |
| 2023-09-30 | $61.48K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $153.69K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $245.91K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $338.12K 10-K · filed 2024-03-22 |
| 2022-06-30 | $64.96K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $64.96K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |